心緣 發問時間: 社會與文化語言 · 1 0 年前

英文高手~進入幫幫忙

Hormone therapy and cardiovascular disease

因荷爾蒙 (內分秘失調)和心血管疾病所引起病變

As in other Western countries,cardiovascular disease(CVD)is the leading cause of

在台灣婦女同樣和西方國家婦女因為罹患子宮頸死亡的人數遠超過癌症死亡人數

death among women in Taiwan, exceeding the mortality from cervical or breast cancer.

Women generally present with CVD after menopause and later than men,

同常一般成年男人的更年期比較婦女來的晚

since menopause-related estrogen deficiency has been considered to be associated

由於大部份是更年期缺乏雌激素之關聯

with an increased risk for.CVD.Thus,coronary artery diseases and stroke are the two

冠狀動脈疾病心臟的)跳動,脈搏

main contributors of mortality among postmenopausal women Observational lstudies

主要中風死亡率觀察的

have reported a reduction in coronary artery diseas risk after hormone therapy(HT)

ranging from 31-44%.However,recent randomized controlled trials that evaluated the

effect of HT on primary and secondary CVD prevention have questioned the efticacy

of HT,despite confriming the lipid-lowering effect of estrogen.However,a cluster of

factors are responsible for the genesis and progression of CVD.Untii wet further

evaluate their specific actions and how these different factors interact , the issue

related to HT and cardiovascular risk will remain unsettled.Since these studies have

contributed to our understanding of the benefits and risks associated with HT,HT use

should be individualized after consideration of the condition of each postmenopausat

patient. Ideally,the efficacy of different preparations and dosagces of HT in

postmenopausal women who are at risk of CVD、before atheromatous lesions have

developed,should be investigated.

已更新項目:

拜託翻譯成中文

有翻譯過的

幫忙修正一下

謝謝!!

2 個已更新項目:

非常急~急~

要交報告

拜託~

1 個解答

評分
  • 1 0 年前
    最佳解答

    激素療法和心血管疾病

    和在其他西方國家,心血管疾病(CVD)是主導的起因

    死亡在婦女之中在臺灣,超出死亡率從子宮頸或乳腺癌。

    婦女比人一般出席以CVD在更年期以後和更晚,

    因為與更年期相關的女性荷爾蒙缺乏認為聯繫

    以一種增加的風險for.CVD.Thus,冠狀動脈病和衝程是二

    死亡率的主要貢獻者在postmenopausal婦女觀察上的lstudies之中

    在激素療法(HT)以後報告了對冠狀動脈diseas風險的減少

    範圍從31-44%.However,評估的最近被隨機化的受控試驗

    HT的作用在主要和次要CVD預防問了efticacy

    HT,儘管confriming女性荷爾蒙的脂質降低作用。然而,群

    因素負責對創世紀和進步CVD.Untii濕更加進一步

    評估他們的具體行動和怎麼這些不同的因素互動,問題

    與HT和心血管風險相關將保持未決定。因為這些研究有

    對對好處和風險的我們的理解貢獻聯合HT, HT用途

    應該在每postmenopausat的情況的考慮以後賦予個性

    患者。 理想地,不同的準備HT效力和dosagces

    是在危?中CVD、的postmenopausal婦女,在atheromatous損害有之前

    開發,應該調查。

    參考資料: 啊知----^_^!!
還有問題?馬上發問,尋求解答。